Does Mifepristone 200 Mg Tablet Abortifacients Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- MIFEPRISTONE/ANTICOAGULANTS; ANTIPLATELETS
- STRONG CYP3A4 INHIBITORS/MAVORIXAFOR (> 200 MG)
- STRONG CYP3A4 INHIBITORS/GEPIRONE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- STR CYP3A4 INHIBITORS; PROTEASE INHIB/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INHIBITORS/PACRITINIB
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- SELECTED STRONG CYP3A4 INHIBITORS/ALFUZOSIN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- MIFEPRISTONE/SELECTED OPIOIDS
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- MIFEPRISTONE/SELECTED CYP3A4 SUBSTRATES
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- SELECTED STRONG CYP3A4 INHIBITORS/LURASIDONE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/RANOLAZINE
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/IVABRADINE
- STRONG CYP3A4 INHIBITORS/SILODOSIN; TAMSULOSIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/IRINOTECAN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- MIFEPRISTONE/CORTICOSTEROIDS
- MIFEPRISTONE/STRONG CYP3A4 INDUCERS
- MIFEPRISTONE/STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR
- MIFEPRISTONE/IDELALISIB
- STRONG CYP3A4 INHIBITORS/AMIODARONE
- MODERATE CYP2C8 INHIBITORS/TOVORAFENIB
- CYP3A4 INHIBITORS AND SUBSTRATES/IVOSIDENIB
- CYP3A4 INHIBITORS AND SUBSTRATES/ENCORAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- COMBINED CYP2C8; CYP2C9; CYP3A4 INHIBITORS/ETRASIMOD
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG CYP3A4 INHIBITORS/LENIOLISIB
- STRONG CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG CYP3A4 INHIBITORS/SPARSENTAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- STRONG CYP3A4 INHIBITORS/PIRTOBRUTINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- SELECTED STRONG CYP3A4 INHIBITORS/CLOZAPINE
- STRONG CYP3A4 INHIBITORS/MITAPIVAT
- STRONG CYP3A4 INHIBITOR/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- MIFEPRISTONE/LEVOKETOCONAZOLE
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- MIFEPRISTONE/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/AVACOPAN
- STRONG CYP3A4 INHIBITORS/ATOGEPANT
- STRONG CYP3A4 INHIBITORS/MOBOCERTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/FEXINIDAZOLE
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- SELECTED CYP3A4 INHIBITORS/CARBAMAZEPINE
- P-GP INHIBITORS THAT CAUSE BLEEDING/BETRIXABAN; DABIGATRAN
- MIFEPRISTONE/RIBOCICLIB
- MIFEPRISTONE/CERITINIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- STRONG CYP3A4 INHIBITORS/TOREMIFENE
- STRONG CYP3A4 INHIBITORS/SUNITINIB
- STRONG CYP3A4 INHIBITORS/PAZOPANIB
- STRONG CYP3A4 INHIBITORS/NILOTINIB
- STRONG CYP3A4 INHIBITORS/LAPATINIB
- STRONG CYP3A4 INHIBITORS/DASATINIB
- STRONG CYP3A4 INHIBITORS/CRIZOTINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/SUVOREXANT
- DUAL STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
- SELECTED STRONG CYP3A4 INHIBITORS/ORAL LEFAMULIN
- STRONG CYP3A4 INHIBITORS/FEDRATINIB
- STRONG CYP3A4 INHIBITORS/ENTRECTINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- STRONG CYP3A4 INHIBITORS/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/GLASDEGIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- SELECTED STRONG CYP3A4 INHIBITOR;PROTEASE INHIB/DISOPYRAMIDE
- STRONG CYP3A4 INHIBITORS/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS/VEMURAFENIB
- STRONG CYP3A4 INHIBITORS/TRABECTEDIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/CARIPRAZINE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/BEDAQUILINE;DELAMANID
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG CYP3A4 INHIBITORS/DACLATASVIR
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- STRONG CYP3A4 INHIBITORS/QUETIAPINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
- STRONG CYP3A4 INHIBITORS/REGORAFENIB
- MIFEPRISTONE (CHRONIC THERAPY)/SELECT CYP2C8; 2C9 SUBSTRATES
- MIFEPRISTONE/HORMONAL CONTRACEPTIVES
- SELECTED STRONG CYP3A4 INHIBITORS/SALMETEROL
- STRONG CYP3A4 INHIBITORS/MARAVIROC
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/TRAZODONE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- MIFEPRISTONE (CUSHING)/ANTICOAGULANTS; ANTIPLATELETS
- STRONG CYP3A4 INHIBITORS/MAVORIXAFOR
- MODERATE CYP2C8 INHIBITORS/RESMETIROM
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- SLT STRONG CYP3A4 INHIBIT/AMLODIPINE; LEVAMLODIPINE
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STRONG CYP3A4 INHIBITORS/QUIZARTINIB
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- MODERATE CYP2C8 INHIBITORS/DAPRODUSTAT
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- STRONG CYP3A4 INHIBITORS/GILTERITINIB
- STRONG CYP3A4 INHIBITORS/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- P-GP INHIBITORS THAT CAUSE BLEEDING/EDOXABAN (<=30 MG)
- P-GP INHIBITORS THAT CAUSE BLEEDING/EDOXABAN (>30 MG)
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- STRONG CYP3A4 INHIBITORS/OSILODROSTAT
- SELECTED STRONG CYP3A4 INHIBITORS/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/MEFLOQUINE
- STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
- DUAL P-GP AND STRONG CYP3A4 INHIBITORS/DAROLUTAMIDE
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/ILOPERIDONE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/CLONAZEPAM
- STRONG CYP3A4 INHIBITORS/MIDOSTAURIN
- STR CYP3A4 INHIBITORS;PROTEASE INHIB/PIMAVANSERIN (<= 10 MG)
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (<= 10 MG)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SLT STRONG CYP3A4 INHIBIT/SELECTED CALCIUM CHANNEL BLOCKERS
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- STRONG CYP3A4 INHIBITORS/CINACALCET
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/ARTEMETHER;LUMEFANTRINE
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.